相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Masayuki Fujii et al.
NATURE MATERIALS (2021)
Rethinking organoid technology through bioengineering
Elena Garreta et al.
NATURE MATERIALS (2021)
Breast tumor-on-chip models: From disease modeling to personalized drug screening
Bano Subia et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions
Xing Jiang et al.
SMALL (2021)
Polymer Conjugation of Docosahexaenoic Acid Potentiates Cardioprotective Therapy in Preclinical Models of Myocardial Ischemia/Reperfusion Injury
Sandra Tejedor et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Human Organoids: Tools for Understanding Biology and Treating Diseases
Frans Schutgens et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020 (2020)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Could 3D models of cancer enhance drug screening?
Virginia Brancato et al.
BIOMATERIALS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Genetically Engineered Pigs to Study Cancer
Daniela Kalla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts
Maiko Okano et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2020)
Grand challenges in nanomedicine
Lin-Ping Wu et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
Kuan-Wei Huang et al.
SCIENCE ADVANCES (2020)
Nanomedicine and cancer immunotherapy
Hai-jun Yu et al.
ACTA PHARMACOLOGICA SINICA (2020)
Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines
Danielle M. Valcourt et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Challenges in nanomedicine clinical translation
Josbert M. Metselaar et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer
Preethi Korangath et al.
SCIENCE ADVANCES (2020)
Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer
Mark Gray et al.
FRONTIERS IN ONCOLOGY (2020)
Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Translational considerations in nanomedicine: The oncology perspective
Alberto A. Gabizon et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Mouse Tumor Models for Advanced Cancer Immunotherapy
Dania S. Chulpanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ag/Au Bimetallic Nanoparticles Inhibit Tumor Growth and Prevent Metastasis in a Mouse Model
Hector Katifelis et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Engineering peptide -targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy
Baksun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The importance of spheroids in analyzing nanomedicine efficacy
Ines Mo et al.
NANOMEDICINE (2020)
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours
Florence Atrafi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
Lea Monteran et al.
SCIENTIFIC REPORTS (2020)
Imaging-assisted anticancer nanotherapy
Anshuman Dasgupta et al.
THERANOSTICS (2020)
Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
Zujun Que et al.
CANCER CELL INTERNATIONAL (2019)
Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression
Juan J. Arroyo-Crespo et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination
Noboru Ideno et al.
LABORATORY INVESTIGATION (2019)
Clinical cancer nanomedicine
Joy Wolfram et al.
NANO TODAY (2019)
Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
Fei Peng et al.
NATURE NANOTECHNOLOGY (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
Combining Nanomedicine and Immunotherapy
Yang Shi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Nathan D. Donahue et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis
Huda I. Atiya et al.
ANTICANCER RESEARCH (2019)
Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment
Seunglee Kwon et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
The role of mouse tumour models in the discovery and development of anticancer drugs
Christopher R. Ireson et al.
BRITISH JOURNAL OF CANCER (2019)
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S
Yaping Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis
Tong Liu et al.
MOLECULAR PHARMACEUTICS (2019)
Gold Nanorod-Assisted Photothermal Therapy Decreases Bleeding during Breast Cancer Surgery in Dogs and Cats
Moustafa R. K. Ali et al.
CANCERS (2019)
Patient-Derived Xenograft Models of Breast Cancer and Their Application
Takahiko Murayama et al.
CELLS (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Zebrafish as a preclinical in vivo screening model for nanomedicines
Sandro Sieber et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Ana S. Nunes et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Vaishali Aggarwal et al.
BIOMOLECULES (2019)
Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer
Elaine Reguera-Nunez et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions
Maryse Fiche et al.
JOURNAL OF PATHOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
Xia Liu et al.
CANCER DISCOVERY (2019)
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up A Phase 1b Clinical Trial
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells
Dong-Min Kim et al.
ACS APPLIED BIO MATERIALS (2019)
Modelling cancer in microfluidic human organs-on-chips
Alexandra Sontheimer-Phelps et al.
NATURE REVIEWS CANCER (2019)
Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study
Jamie R. Kutasovic et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
Inbred or Outbred? Genetic Diversity in Laboratory Rodent Colonies
Thomas D. Brekke et al.
G3-GENES GENOMES GENETICS (2018)
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Liangzhu Feng et al.
NATIONAL SCIENCE REVIEW (2018)
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression
Dana A. M. Mustafa et al.
ACTA NEUROPATHOLOGICA (2018)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Anticancer Activity Driven by Drug Linker Modification in a Polyglutamic Acid-Based Combination-Drug Conjugate
Juan J. Arroyo-Crespo et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems
Yongli Chen et al.
ANALYTICA CHIMICA ACTA (2018)
Humanized Mice as Unique Tools for Human-Specific Studies
Kylie Su Mei Yong et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer
Jasmine Miller-Kleinhenz et al.
BIOMATERIALS (2018)
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
Carrie J. Lovitt et al.
BMC CANCER (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Genetically engineered pigs as models for human disease
Carolin Perleberg et al.
DISEASE MODELS & MECHANISMS (2018)
Co-delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy
Qing Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanoparticle transport pathways into tumors
S. M. Moghimi et al.
JOURNAL OF NANOPARTICLE RESEARCH (2018)
Translational gaps in animal models of human infusion reactions to nanomedicines
S. Moein Moghimi et al.
NANOMEDICINE (2018)
Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles
Hongxu Lu et al.
SMALL (2018)
Zebrafish (Danio rerio) model as an early stage screening tool to study the biodistribution and toxicity profile of doxorubicin-loaded mixed micelles
Maria Natalia Calienni et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Shantanu Pradhan et al.
SCIENTIFIC REPORTS (2018)
Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment
Juan J. Arroyo-Crespo et al.
BIOMATERIALS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Folate-receptor-targeted laser-activable poly(lactide-co-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy
Fengqiu Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery
Thinzar M. Lwin et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Biomimetic nanoflowers by self-assembly of nanozymes to induce intracellular oxidative damage against hypoxic tumors
Zhenzhen Wang et al.
NATURE COMMUNICATIONS (2018)
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention
Lewis A. Quayle et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles
Parisa Foroozandeh et al.
NANOSCALE RESEARCH LETTERS (2018)
Roadmap and strategy for overcoming infusion reactions to nanomedicines
Janos Szebeni et al.
NATURE NANOTECHNOLOGY (2018)
Mouse Models for Cancer Immunotherapy Research
Brian Olson et al.
CANCER DISCOVERY (2018)
3D Bioprinting of Breast Cancer Models for Drug Resistance Study
Ying Wang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
John P. A. Ioannidis et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment
Stuart P. Atkinson et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
Experimental Models as Refined Translational Tools for Breast Cancer Research
Eduardo Costa et al.
SCIENTIA PHARMACEUTICA (2018)
Nanomedicine: is it lost in translation?
Khaled Greish et al.
THERAPEUTIC DELIVERY (2018)
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn et al.
ACS NANO (2018)
Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids
Venktesh S. Shirure et al.
LAB ON A CHIP (2018)
Genetically engineered mouse models in oncology research and cancer medicine
Kelly Kersten et al.
EMBO MOLECULAR MEDICINE (2017)
Nanoparticles for imaging and treatment of metastatic breast cancer
Qingxin Mu et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer
Charles J. Bowerman et al.
NANO LETTERS (2017)
Risk Factors and Preventions of Breast Cancer
Yi-Sheng Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy
Jing Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy
Feihu Wang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Advances in multicellular spheroids formation
X. Cui et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Veronique Dieras et al.
LANCET ONCOLOGY (2017)
Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models
Andrew T. Lucas et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines
Gianpiero Lazzari et al.
POLYMER CHEMISTRY (2017)
In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles
Altug Ozcelikkale et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Nanoparticle interactions with the immune system: clinical implications for Liposome-Based cancer chemotherapy
Ninh M. La-Beck et al.
FRONTIERS IN IMMUNOLOGY (2017)
A novel nanopolymer based tumor targeted delivery system for paclitaxel
A. T. Singh et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mouse models of metastasis: progress and prospects
Laura Gomez-Cuadrado et al.
DISEASE MODELS & MECHANISMS (2017)
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tianjian Yu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications
Keon Yong Lee et al.
BIOSCIENCE REPORTS (2017)
In vivo models in breast cancer research: progress, challenges and future directions
Ingunn Holen et al.
DISEASE MODELS & MECHANISMS (2017)
The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials
L. Ansari et al.
CANCER GENE THERAPY (2017)
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
Hong-Yan Xie et al.
CHINESE JOURNAL OF CANCER (2017)
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer
Kenji Tezuka et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Methods for the In Vitro Characterization of Nanomedicines-Biological Component Interaction
Cristina Fornaguera et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
Wojciech G. Lesniak et al.
BIOCONJUGATE CHEMISTRY (2016)
Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment
Kuo-Ching Mei et al.
BIOMATERIALS (2016)
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
Z. A. Nahleh et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Lacey E. Dobrolecki et al.
CANCER AND METASTASIS REVIEWS (2016)
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
George Sflomos et al.
CANCER CELL (2016)
Relevant Physicochemical Descriptors of Soft Nanomedicines to Bypass Biological Barriers
Amaya Nino-Pariente et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis
Moustafa R. K. Ali et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis
Rachel Eyre et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2016)
Common swine models of cardiovascular disease for research and training
Veronica Crisostomo et al.
LAB ANIMAL (2016)
The cell fate: senescence or quiescence
Menderes Yusuf Terzi et al.
MOLECULAR BIOLOGY REPORTS (2016)
Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review
Giovana Maria Fioramonti Calixto et al.
MOLECULES (2016)
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
Saeid Zanganeh et al.
NATURE NANOTECHNOLOGY (2016)
Pigs as models of human cancers
Tatiana Flisikowska et al.
THERIOGENOLOGY (2016)
Current understanding of interactions between nanoparticles and the immune system
Marina A. Dobrovolskaia et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Dogs as a Model for Cancer
Heather L. Gardner et al.
ANNUAL REVIEW OF ANIMAL BIOSCIENCES, VOL 4 (2016)
Engineered Swine Models of Cancer
Adrienne L. Watson et al.
FRONTIERS IN GENETICS (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Canine cancer immunotherapy studies: linking mouse and human
Jiwon S. Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice
Madhavi Puchalapalli et al.
PLOS ONE (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles
Qizhi Hu et al.
BIOMATERIALS (2015)
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
Charlene M. Dawidczyk et al.
CANCER RESEARCH (2015)
Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model
Gopal Venkatesh Shavi et al.
LIFE SCIENCES (2015)
Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations
Yan Li et al.
MOLECULAR PHARMACEUTICS (2015)
3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation
Pallavi Sethi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Role of the Tumor Microenvironment in Breast Cancer
Savas D. Soysal et al.
PATHOBIOLOGY (2015)
Alternatives to animal testing: A review
Sonali K. Doke et al.
SAUDI PHARMACEUTICAL JOURNAL (2015)
A bladder cancer microenvironment simulation system based on a microfluidic co-culture model
Peng-fei Liu et al.
ONCOTARGET (2015)
A porcine model system of BRCA1 driven breast cancer
Howard Donninger et al.
FRONTIERS IN GENETICS (2015)
Dissecting the Molecular Mechanism of Apoptosis during Photothermal Therapy Using Gold Nanoprisms
Marta Perez-Hernandez et al.
ACS NANO (2015)
PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
Hallie Wimberly et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles
Krista Marie Vincent et al.
BREAST CANCER RESEARCH (2015)
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O'Reilly et al.
BBA CLINICAL (2015)
Drug discovery through stem cell-based organoid models
Adrian Ranga et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model
Anna I. Astashkina et al.
BIOMATERIALS (2014)
Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
Gina Song et al.
CLINICAL CANCER RESEARCH (2014)
Naturally Occurring Cancers in Dogs: Insights for Translational Genetics and Medicine
Carlos E. Alvarez
ILAR JOURNAL (2014)
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
Charlene M. Dawidczyk et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects
Sutapa Barua et al.
NANO TODAY (2014)
Animal models and therapeutic molecular targets of cancer: utility and limitations
Maria Cekanova et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Assessment of Juvenile Pigs to Serve as Human Pediatric Surrogates for Preclinical Formulation Pharmacokinetic Testing
Wyatt J. Roth et al.
AAPS JOURNAL (2013)
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Change in the microenvironment of breast cancer studied by FTIR imaging
S. Kumar et al.
ANALYST (2013)
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
Michel DuPage et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
Stephen W. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models
Qinjie Wu et al.
NANOSCALE (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
Carey K. Anders et al.
PLOS ONE (2013)
Evaluation of Nanoparticle Uptake in Co-culture Cancer Models
Elisabete C. Costa et al.
PLOS ONE (2013)
Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours
Karyn S. Ho et al.
BMC CANCER (2012)
Liposomal paclitaxel formulations
Stepan Koudelka et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
VIP-targeted cytotoxic nanomedicine for breast cancer
Aparna Dagar et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
Parvin F. Peddi et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Joaquim Calbo et al.
CANCER CELL (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study
Ballari Brahmachari et al.
INDIAN JOURNAL OF PHARMACOLOGY (2011)
Nanotherapeutics in angiogenesis: synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos
Jinping Cheng et al.
International Journal of Nanomedicine (2011)
Nanomedicine(s) under the Microscope
Ruth Duncan et al.
MOLECULAR PHARMACEUTICS (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Dog models of naturally occurring cancer
Jennie L. Rowell et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
W. T. Lim et al.
ANNALS OF ONCOLOGY (2010)
Pulsed Ultrasound Enhances Nanoparticle Penetration into Breast Cancer Spheroids
Stephanie J. Grainger et al.
MOLECULAR PHARMACEUTICS (2010)
Targeting nanoparticles to cancer
M. Wang et al.
PHARMACOLOGICAL RESEARCH (2010)
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Chia-Chen Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effects of Branching Architecture and Linker on the Activity of Hyperbranched Polymer-Drug Conjugates
Omathanu Perumal et al.
BIOCONJUGATE CHEMISTRY (2009)
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
Qian Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer
Theresa A. DiMeo et al.
CANCER RESEARCH (2009)
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
Leonard W. Seymour et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
N-methylnitrosourea Induced Breast Cancer in Rat, the Histopathology of the Resulting Tumours and its Drawbacks as a Model
M. Perse et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
Erin R. Gardner et al.
CLINICAL CANCER RESEARCH (2008)
Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy
Madhuri Kakarala et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Science and society - Translation of new cancer treatments from pet dogs to humans
Melissa Paoloni et al.
NATURE REVIEWS CANCER (2008)
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancerle
Douglas Hanahan et al.
GENES & DEVELOPMENT (2007)
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
Paraic A. Kenny et al.
MOLECULAR ONCOLOGY (2007)
Modelling breast cancer: one size does not fit all
Tracy Vargo-Gogola et al.
NATURE REVIEWS CANCER (2007)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Genome sequence, comparative analysis and haplotype structure of the domestic dog
K Lindblad-Toh et al.
NATURE (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
The lineage decisions of helper T cells
KM Murphy et al.
NATURE REVIEWS IMMUNOLOGY (2002)
A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer
KJ O'Byrne et al.
BRITISH JOURNAL OF CANCER (2002)
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma
L Harris et al.
CANCER (2002)
Detection of VIP receptors in MNU-Induced breast cancer in rats: Implications for breast cancer targeting
S Dagar et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
M-1/M-2 macrophages and the Th1/Th2 paradigm
CD Mills et al.
JOURNAL OF IMMUNOLOGY (2000)
A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
DJ Jerry et al.
ONCOGENE (2000)
分享论文
